StockWatch
·

NORRIS MEDICINES LTD. Q3 FY25 Results

NORRISQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue1.1112.8%
Total Income1.1112.7%
Expenditure1.3914.7%
PBT-0.2821.9%
Net Profit-0.2821.9%
OPM-49.10%3.36pp
NPM-25.43%3.00pp
EPS-0.2822.2%
View full financials

Informational and educational content only. Not investment advice.